140 related articles for article (PubMed ID: 36125908)
1. FOXO1 is downregulated in obese mice subjected to short-term strength training.
Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
[TBL] [Abstract][Full Text] [Related]
2. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
3. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
[TBL] [Abstract][Full Text] [Related]
4. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
5. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
6. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Strength Exercise Reduces Hepatic Insulin Resistance in Obese Mice by Reducing PTP1B Content, Regardless of Changes in Body Weight.
da Cruz Rodrigues KC; Martins Pereira R; Peruca GF; Torres Barbosa LW; Ramos Sant'Ana M; Rosetto Muñoz V; Morelli AP; Moreira Simabuco F; Sanchez Ramos da Silva A; Esper Cintra D; Rochete Ropelle E; Pauli JR; de Moura LP
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203825
[TBL] [Abstract][Full Text] [Related]
9. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
[TBL] [Abstract][Full Text] [Related]
10. Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice.
Souza Pauli LS; Ropelle EC; de Souza CT; Cintra DE; da Silva AS; de Almeida Rodrigues B; de Moura LP; Marinho R; de Oliveira V; Katashima CK; Pauli JR; Ropelle ER
J Physiol; 2014 Mar; 592(6):1325-40. PubMed ID: 24396063
[TBL] [Abstract][Full Text] [Related]
11. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
[TBL] [Abstract][Full Text] [Related]
12. Strength exercise reduces hepatic pyruvate carboxylase and gluconeogenesis in DIO mice.
Pereira RM; Rodrigues KCDC; Sant'Ana MR; Peruca GF; Morelli AP; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Endocrinol; 2020 Nov; 247(2):127-138. PubMed ID: 32805709
[TBL] [Abstract][Full Text] [Related]
13. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
Yan C; Li J; Feng S; Li Y; Tan L
Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
Zhu X; Wu YB; Zhou J; Kang DM
Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]